Ambea ABCHIX:AMBEAS 82 EBITDA Margin % is 17.96% as of Mar. 2026, which is 27% above its 10-year median of 14.15. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 82/100 and a GF Value™ of kr110.05 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Ambea AB ranks better than 70.21% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ambea AB's EBITDA for the
three
months ended in Mar. 2026 was kr758 Mil. Ambea AB's Revenue for the
three
months ended in Mar. 2026 was kr4,220 Mil. Therefore, Ambea AB's EBITDA margin for the quarter that ended in Mar. 2026 was 17.96%.
Ambea AB (CHIX:AMBEAs) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ambea AB EBITDA Margin % Related Terms
Ambea AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ambea AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AMBEAS vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Ambea AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ambea AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambea AB (CHIX:AMBEAS) has a EBITDA Margin % of 17.96% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ambea AB and its competitors. This is 27% above median its historical median of 14.15. Over the past decade, Ambea AB's EBITDA Margin % has ranged from 6.92 to 18.44. According to the industry distribution chart, Ambea AB ranks #199 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 29.8%.
Is Ambea AB's EBITDA Margin % too high?
Ambea AB's current EBITDA Margin % of 17.96% is 27% above median its 10-year median of 14.15. Over the past 10 years, this metric has ranged from a low of 6.92 to a high of 18.44. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Ambea AB's value of 17.96% is 75.9% above this industry median. Based on the distribution chart, Ambea AB ranks #199 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ambea AB has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #199 out of 668 companies for EBITDA Margin %. This puts Ambea AB in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Ambea AB's value of 17.96% is 75.9% above this benchmark. Historically, Ambea AB's own EBITDA Margin % has ranged from 6.92 to 18.44 over the past decade. While the company's 10-year median is 14.15 vs. the industry median of 10.21, Ambea AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambea AB's current EBITDA Margin % of 17.96% is 75.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ambea AB and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current EBITDA Margin % is 17.96%, which is 27% above median its own 10-year median of 14.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr110.05, compared to a current price of kr140.40 — trading 27.6% above its estimated fair value. The current EBITDA Margin % is 17.96%, which is 27% above median its 10-year median of 14.15 and 75.9% above the Healthcare Providers & Services industry median of 10.21. Ambea AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current EBITDA Margin % is 17.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr140.40 is trading 27.6% above its estimated GF Value™ of kr110.05.
GuruFocus considers Ambea AB to be Modestly Overvalued.
Key valuation signals for CHIX:AMBEAS:
EBITDA Margin %: 17.96% (27% above median its 10-year median of 14.15)
GF Value™: kr110.05 vs. price of kr140.40 (27.6% above fair value)
Industry Position: 75.9% above the Healthcare Providers & Services median (#199 of 668)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
82GF Score
Get the complete analysis for CHIX:AMBEAS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
